Speaker Profile
Head of Medical Diagnostics, US Medical Affairs Oncology, AstraZeneca
Biography
Dr. Omar Perez has over 17 years designing, deploying, and leading high-visibility oncology initiatives supporting global companion diagnostic developments, strategic partnerships and commercialization opportunities. Before joining AstraZeneca, he oversaw the global CDx developments for the GSK oncology portfolio, leading to diagnostic products for niraparib and dostarlimab. During his time at Pfizer, he led global CDx activities supporting the drug approvals of crizotinib, lorlatinib, dacomitinib talazoparib and inotuzomab. Notably, he led the first FDA approved NGS product for multiple targeted agents and helped establish the Center for Precision Medicine in LATAM to support Pfizer oncology products. Dr. Perezs background includes roles in biotech and diagnostic companies, including co-founding Nodality, a diagnostic company focused on hematological malignancies. He is an inventor of the multiparametric phospho-proteomic flow technologies and an author of 37 publications and 35 patents.
Session Abstract – PMWC 2025 Silicon Valley
Track Co-Chairs:
Cherodeep Goswami, UW Health
- PMWC 2025 Award Ceremony
Pioneer Honoree: Paul J. Chang, University of Chicago - Keynote: AI in Radiology: A Reality Check (Climbing out of the Trough of Disillusionment)
- Paul J. Chang, University of Chicago
- AI in Radiology and Imaging Applications (PANEL)
Chair: Curtis P Langlotz, Stanford
- Paul J. Chang, University of Chicago
- Sharmila Majumdar, UCSF
- Eliot Siegel, VA Maryland Healthcare System
- Katherine Andriole, Brigham and Women's Hospital - Using Imaging AI to Better Understand Health and Aging
- Daniel Durand, Prenuvo
- AI Transforming Standard-of-Care Imaging into Precision Diagnostics
- Angel Alberich, Quibim
- Accelerating Risk Assessment and Diagnosis with AI
Chair: Pavan Anne, ZS
- Omar Perez, AstraZeneca
- Charles Powell, Mount Sinai - Overcoming Practice Gaps in Precision Medicine: Addressing Patient Leakage (PANEL)
Chair: Joe Zaccaria, KPMG
- Ed Kim, City of Hope
- Chris Scotto DiVetta, Tempus
- Karlo Martin, HCA Healthcare
- Shared Opportunities to Unlock AI's Potential in R&D (PANEL)
Chair: Brice Sarver, ZS
- Carlyn Crisostomo, Amgen
- Bill Mayo, BMS
- Stacie Calad-Thomson, Nvidia
- AI-Powered Remote Monitoring and Mental Health: Innovations and Challenges
- Sam Perli, ThinkHat
- Shah Nawaz, Regeneron
- David Rhew, Microsoft
- AI Unlocks the Clinical Utility of Spatialomics
- Matthew Goldberg, Castle Bio
- Practical Implications of Ethical Challenges in AI-driven Precision Medicine(PANEL)
Chair: Cherodeep Goswami, UW Health
- Tina Hernandez-Boussard, Stanford
- Lucia Savage, Omada Health
- Sean Hain, Epic
- Misha Mehta, Neev Kolte & Brave Ronil Foundation
